BWAY News

Latest breaking news and updates for BWAY stock.

Track all markets on TradingView

Neurolief Prepares for Launch of its Proliv™Rx System for Major Depressive Disorder with Strategic Investment from BrainsWay

CORAL SPRINGS, Fla. and NETANYA, Israel, Aug. 21, 2025 /PRNewswire/ -- Neurolief, a pioneering brain stimulation company specializing in non-invasive neuromodulation therapies, today announced a st...

How does Neurolief’s non‑invasive neuromodulation platform compare to existing MDD treatments and competitor neuromodulation technologies in terms of efficacy, regulatory pathway, and pricing? What are the expected revenue timelines and market penetration rates for the Proliv™Rx system targeting Major Depressive Disorder? How will BrainsWay’s strategic investment in Neurolief affect BWAY’s stock valuation and liquidity?
Funding
4 days ago
Read more prnewswire

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home

What regulatory, reimbursement, or adoption challenges could affect the rollout of home‑based neuromodulation therapies and impact the stock's upside? What is the size and growth rate of the at‑home neuromodulation mental‑health market, and how does BrainsWay's offering compare to existing competitors? How will BrainsWay's investment in Neurolief influence its short‑term earnings guidance and stock valuation?
Mergers
4 days ago
Read more globenewswire